RecruitingNCT00286637

Novel Glaucoma Diagnostics

Novel Diagnostics for Ocular Structure

Sponsor

Wills Eye

Enrollment

5,000 participants

Start Date

Aug 1, 2000

Study Type

OBSERVATIONAL

Conditions

Glaucoma Macular Disease

Summary

The purpose of this research is to evaluate novel technologies for the assessment of ocular structure and function, including the scanning device called Optical Coherence Tomography (OCT). We will test the OCT and other devices in their ability to image diseases of the eye and also compare the measurements made with OCT to those of other imaging and visual field devices approved by the Food and Drug Administration (FDA). OCT may be useful for the early diagnosis and monitoring of a variety of types of eye diseases

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing new tools and methods for diagnosing glaucoma (an eye disease that can cause vision loss) earlier and more accurately than current methods allow. **You may be eligible if...** - You have been diagnosed with glaucoma or are suspected of having it - You have elevated eye pressure (a key risk factor for glaucoma) - You are a healthy adult willing to have eye tests done for comparison **You may NOT be eligible if...** - You have had certain types of eye surgery that could affect the test results - You have another serious eye condition that makes testing difficult or unsafe - You are unable to sit still for the imaging or testing equipment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.